• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种分子传感器可测定 SARS-CoV-2 木瓜蛋白酶样蛋白酶的泛素底物特异性。

A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease.

机构信息

Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.

Department of Biochemistry & Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

出版信息

Cell Rep. 2021 Sep 28;36(13):109754. doi: 10.1016/j.celrep.2021.109754. Epub 2021 Sep 8.

DOI:10.1016/j.celrep.2021.109754
PMID:34547223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8423903/
Abstract

The SARS-CoV-2 papain-like protease (PLpro) is a target for antiviral drug development. It is essential for processing viral polyproteins for replication and functions in host immune evasion by cleaving ubiquitin (Ub) and ubiquitin-like protein (Ubl) conjugates. While highly conserved, SARS-CoV-2 and SARS-CoV PLpro have contrasting Ub/Ubl substrate preferences. Using a combination of structural analyses and functional assays, we identify a molecular sensor within the S1 Ub-binding site of PLpro that serves as a key determinant of substrate specificity. Variations within the S1 sensor specifically alter cleavage of Ub substrates but not of the Ubl interferon-stimulated gene 15 protein (ISG15). Significantly, a variant of concern associated with immune evasion carries a mutation in the S1 sensor that enhances PLpro activity on Ub substrates. Collectively, our data identify the S1 sensor region as a potential hotspot of variability that could alter host antiviral immune responses to newly emerging SARS-CoV-2 lineages.

摘要

严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)的木瓜蛋白酶样蛋白酶(PLpro)是抗病毒药物开发的靶标。它对于病毒多蛋白的复制加工至关重要,通过切割泛素(Ub)和泛素样蛋白(Ubl)缀合物来实现宿主免疫逃逸。尽管高度保守,但 SARS-CoV-2 和 SARS-CoV 的 PLpro 对 Ub/Ubl 底物具有不同的偏好。我们使用结构分析和功能测定的组合,确定了 PLpro 的 S1 Ub 结合位点内的分子传感器,该传感器是决定底物特异性的关键决定因素。S1 传感器内的变异特异性改变 Ub 底物的切割,但不改变 Ubl 干扰素刺激基因 15 蛋白(ISG15)的切割。重要的是,与免疫逃逸相关的一个关注变体在 S1 传感器中携带一个突变,该突变增强了 PLpro 在 Ub 底物上的活性。总的来说,我们的数据确定了 S1 传感器区域作为一个潜在的变异热点,可能会改变宿主对新出现的 SARS-CoV-2 谱系的抗病毒免疫反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/847aa138ee5b/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/63b6b845f87a/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/4ac31b0caeb4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/ad4260bb10ee/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/a10a2146e786/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/847aa138ee5b/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/63b6b845f87a/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/4ac31b0caeb4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/ad4260bb10ee/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/a10a2146e786/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2679/8423903/847aa138ee5b/gr4_lrg.jpg

相似文献

1
A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease.一种分子传感器可测定 SARS-CoV-2 木瓜蛋白酶样蛋白酶的泛素底物特异性。
Cell Rep. 2021 Sep 28;36(13):109754. doi: 10.1016/j.celrep.2021.109754. Epub 2021 Sep 8.
2
Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15).冠状病毒 PLpro 蛋白酶与结合型和游离型干扰素刺激基因产物 15(ISG15)的免疫调节作用。
Semin Cell Dev Biol. 2022 Dec;132:16-26. doi: 10.1016/j.semcdb.2022.06.005. Epub 2022 Jun 25.
3
Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin.双结构域识别决定了 SARS-CoV-2 PLpro 对人 ISG15 和 K48 连接的二泛素的选择性。
Nat Commun. 2023 Apr 25;14(1):2366. doi: 10.1038/s41467-023-38031-5.
4
Characterization of the Ubiquitin and ISG15 Deconjugase Activity of SARS-CoV-1 and SARS-CoV-2 Papain-Like Protease.严重急性呼吸综合征冠状病毒1型和2型木瓜蛋白酶样蛋白酶的泛素及ISG15去结合酶活性的表征
Methods Mol Biol. 2023;2591:171-188. doi: 10.1007/978-1-0716-2803-4_11.
5
SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.严重急性呼吸综合征冠状病毒木瓜样蛋白酶是一种独特的、具有赖氨酸48连接特异性的双分布去泛素化酶。
Biochem J. 2015 Jun 1;468(2):215-26. doi: 10.1042/BJ20141170.
6
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.木瓜蛋白酶样蛋白酶调节新型冠状病毒2的病毒传播和固有免疫。
Nature. 2020 Nov;587(7835):657-662. doi: 10.1038/s41586-020-2601-5. Epub 2020 Jul 29.
7
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.新型冠状病毒木瓜样蛋白酶的去泛素酶和去ISG15酶活性的表征及非共价抑制作用
ACS Infect Dis. 2020 Aug 14;6(8):2099-2109. doi: 10.1021/acsinfecdis.0c00168. Epub 2020 Jun 4.
8
Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.中东呼吸综合征冠状病毒nsp3木瓜蛋白酶样蛋白酶结构域的催化功能及底物特异性
J Virol. 2014 Nov;88(21):12511-27. doi: 10.1128/JVI.01294-14. Epub 2014 Aug 20.
9
The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.严重急性呼吸综合征冠状病毒的木瓜蛋白酶样蛋白酶是一种去泛素化酶。
J Virol. 2005 Dec;79(24):15199-208. doi: 10.1128/JVI.79.24.15199-15208.2005.
10
Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.严重急性呼吸综合征冠状病毒木瓜样蛋白酶的泛素连接特异性和去ISGylation活性的结构基础
PLoS Pathog. 2014 May 22;10(5):e1004113. doi: 10.1371/journal.ppat.1004113. eCollection 2014 May.

引用本文的文献

1
DIG-DUBs: mechanisms and functions of ISG15 deconjugation by human and viral cross-reactive ubiquitin proteases.DIG-DUBs:人类和病毒交叉反应性泛素蛋白酶对ISG15去缀合的机制与功能
Biochem Soc Trans. 2025 Jul 9. doi: 10.1042/BST20240859.
2
Detecting SARS-CoV-2 cryptic lineages using publicly available whole genome wastewater sequencing data.利用公开的全基因组废水测序数据检测新冠病毒隐匿谱系
PLoS Pathog. 2025 Jun 9;21(6):e1012850. doi: 10.1371/journal.ppat.1012850. eCollection 2025 Jun.
3
Frustration in physiology and molecular medicine.

本文引用的文献

1
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.SARS-CoV-2 从高中和性的 COVID-19 恢复期血浆中逃逸。
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36). doi: 10.1073/pnas.2103154118.
2
Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2.开发针对 SARS-CoV-2 的木瓜蛋白酶样蛋白酶的高效和选择性抑制剂。
Cell Chem Biol. 2021 Jun 17;28(6):855-865.e9. doi: 10.1016/j.chembiol.2021.04.020. Epub 2021 Apr 27.
3
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
生理学与分子医学中的挫折感。
Mol Aspects Med. 2025 Jun;103:101362. doi: 10.1016/j.mam.2025.101362. Epub 2025 Apr 23.
4
Frustration In Physiology And Molecular Medicine.生理学与分子医学中的挫折
ArXiv. 2025 Feb 6:arXiv:2502.03851v1.
5
Intrahost evolution leading to distinct lineages in the upper and lower respiratory tracts during SARS-CoV-2 prolonged infection.在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)长期感染期间,宿主体内的进化导致上呼吸道和下呼吸道出现不同的谱系。
Virus Evol. 2024 Aug 31;10(1):veae073. doi: 10.1093/ve/veae073. eCollection 2024.
6
Subsequent Waves of Convergent Evolution in SARS-CoV-2 Genes and Proteins.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因和蛋白质的后续趋同进化浪潮
Vaccines (Basel). 2024 Aug 5;12(8):887. doi: 10.3390/vaccines12080887.
7
Lessons learnt from broad-spectrum coronavirus antiviral drug discovery.从广谱冠状病毒抗病毒药物研发中汲取的经验教训。
Expert Opin Drug Discov. 2024 Sep;19(9):1023-1041. doi: 10.1080/17460441.2024.2385598. Epub 2024 Jul 30.
8
Modeling of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-2 considering the protein flexibility by using molecular dynamics and cross-docking.通过分子动力学和交叉对接考虑蛋白质灵活性对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)木瓜蛋白酶样蛋白酶(PLpro)的非共价抑制剂进行建模。
Front Mol Biosci. 2024 Mar 27;11:1374364. doi: 10.3389/fmolb.2024.1374364. eCollection 2024.
9
Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo.SARS-CoV-2 木瓜蛋白酶样蛋白酶的去泛素化活性不会影响病毒在体内的复制或先天免疫反应。
PLoS Pathog. 2024 Mar 25;20(3):e1012100. doi: 10.1371/journal.ppat.1012100. eCollection 2024 Mar.
10
Local energetic frustration conservation in protein families and superfamilies.蛋白质家族和超家族中的局部能量挫折守恒。
Nat Commun. 2023 Dec 16;14(1):8379. doi: 10.1038/s41467-023-43801-2.
多种严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体可逃避疫苗诱导的体液免疫的中和作用。
Cell. 2021 Apr 29;184(9):2523. doi: 10.1016/j.cell.2021.04.006.
4
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.SARS-CoV-2 501Y.V2 逃避恢复期血浆中和作用。
Nature. 2021 May;593(7857):142-146. doi: 10.1038/s41586-021-03471-w. Epub 2021 Mar 29.
5
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.mRNA 疫苗诱导的针对 SARS-CoV-2 和循环变异株的抗体。
Nature. 2021 Apr;592(7855):616-622. doi: 10.1038/s41586-021-03324-6. Epub 2021 Feb 10.
6
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.BNT162b2 疫苗诱导的血清对 SARS-CoV-2 刺突 69/70 缺失、E484K 和 N501Y 变异株的中和作用。
Nat Med. 2021 Apr;27(4):620-621. doi: 10.1038/s41591-021-01270-4. Epub 2021 Feb 8.
7
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors.SARS-CoV-2 木瓜蛋白酶样蛋白酶的结构及其与非共价抑制剂的复合物。
Nat Commun. 2021 Feb 2;12(1):743. doi: 10.1038/s41467-021-21060-3.
8
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery.GRL0617 与 SARS-CoV-2 PLpro 的复杂结构揭示了抗病毒药物发现的热点。
Nat Commun. 2021 Jan 20;12(1):488. doi: 10.1038/s41467-020-20718-8.
9
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design.抑制剂结合的 SARS-CoV-2 木瓜蛋白酶样蛋白酶的活性分析和晶体结构:抗 COVID-19 药物设计的框架。
Sci Adv. 2020 Oct 16;6(42). doi: 10.1126/sciadv.abd4596. Print 2020 Oct.
10
An online coronavirus analysis platform from the National Genomics Data Center.国家基因组科学数据中心的在线冠状病毒分析平台。
Zool Res. 2020 Nov 18;41(6):705-708. doi: 10.24272/j.issn.2095-8137.2020.065.